...
首页> 外文期刊>Journal of Nanoparticle Research >A rationale on the role of intermediate Au(III)–vitamin C complexation in the production of gold nanoparticles
【24h】

A rationale on the role of intermediate Au(III)–vitamin C complexation in the production of gold nanoparticles

机译:中间金(III)-维生素C络合在金纳米颗粒生产中的作用的基本原理

获取原文
获取原文并翻译 | 示例
           

摘要

Preparation of gold nanoparticles, particularly gold nanorods, by wet chemistry processes involves gold seeds, an Au(III) salt, structure directing surfactants, and metal ion additives in the growth solution into which a weak reducing agent is added. The most commonly employed weak reducing agent is l-ascorbic acid (vitamin C) which is known to reduce many metal ions in the solution phase and form complexes with relatively low stability constants. A purple-gray gold–ascorbate compound, obtained from the reaction of sodium tetrachloroaurate(III) with sodium ascorbate, is now reported. The compound possesses the expected structural features of vitamin C–metal complexes as verified by its 13C CP-MAS NMR spectrum. A discussion is also presented on the possibility of gold–ascorbate complexation operating in gold nanoparticle formation.
机译:通过湿化学方法制备金纳米颗粒,特别是金纳米棒,涉及在生长溶液中添加了弱还原剂的金种子,Au(III)盐,结构导向表面活性剂和金属离子添加剂。最常用的弱还原剂是1-抗坏血酸(维生素C),已知它可还原溶液相中的许多金属离子并形成稳定性常数相对较低的络合物。现在报道了一种紫色灰色的抗坏血酸金化合物,该化合物是由四氯金酸钠(III)与抗坏血酸钠反应制得的。通过13 C CP-MAS NMR光谱证实,该化合物具有维生素C-金属配合物的预期结构特征。还讨论了金-抗坏血酸络合作用在金纳米颗粒形成中的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号